A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis - Sanchorawala, Vaishali; Schönland, Stefan (Blood, 2017)
Prepublished online as Blood First Edition paper, 26 May 2017